Evidence map›Paper›PMID 35212482›Full record

ArticleMicrobiologyOpen2022

Efficacy of antifungal agents against fungal spores: An in vitro study using microplate laser nephelometry and an artificially infected 3D skin model.

Sarah Fink, Anke Burmester, Uta-Christina Hipler, Claudia Neumeister, Marcus R Götz, Cornelia Wiegand

Open access · goldAbstract read
In one paragraph

Article in MicrobiologyOpen, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 31 citations in OpenAlex.

  1. Rising antifungal resistance inFrontiers in microbiology · 2026
    Review
  2. Article
  3. Article
  4. Impact of Nitric Oxide-Release Kinetics on Antifungal Activity.Journal of fungi (Basel, Switzerland) · 2024
    Article
  5. Article
  6. A New Genotype ofJournal of fungi (Basel, Switzerland) · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Sarah FinkDepartment of Dermatology, University Hospital Jena, Jena, Germany.
Anke BurmesterDepartment of Dermatology, University Hospital Jena, Jena, Germany.
Uta-Christina HiplerDepartment of Dermatology, University Hospital Jena, Jena, Germany.
Claudia NeumeisterDr. Pfleger Arzneimittel GmbH, Bamberg, Germany.
Marcus R GötzDr. Pfleger Arzneimittel GmbH, Bamberg, Germany.
Cornelia WiegandDepartment of Dermatology, University Hospital Jena, Jena, Germany.ORCID 0000-0001-7802-2785
Jena University Hospital · DEDr. Pfleger Arzneimittel (Germany) · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dermal fungal infections seem to have increased over recent years. There is further a shift from anthropophilic dermatophytes to a growing prevalence of zoophilic species and the emergence of resistant strains. New antifungals are needed to combat these fungi and their resting spores. This study aimed to investigate the sporicidal effects of sertaconazole nitrate using microplate laser nephelometry against the microconidia of Trichophyton, chlamydospores of Epidermophyton, blastospores of Candida, and conidia of the mold Scopulariopsis brevicaulis. The results obtained were compared with those from ciclopirox olamine and terbinafine. The sporicidal activity was further determined using infected three-dimensional full skin models to determine the antifungal effects in the presence of human cells. Sertaconazole nitrate inhibited the growth of dermatophytes, molds, and yeasts. Ciclopirox olamine also had good antifungal activity, although higher concentrations were needed compared to sertaconazole nitrate. Terbinafine was highly effective against most dermatophytes, but higher concentrations were required to kill the resistant strain Trichophyton indotineae. Sertaconazole nitrate, ciclopirox olamine, and terbinafine had no negative effects on full skin models. Sertaconazole nitrate reduced the growth of fungal and yeast spores over 72 h. Ciclopirox olamine and terbinafine also inhibited the growth of dermatophytes and molds but had significantly lower effects on the yeast. Sertaconazole nitrate might have advantages over the commonly used antifungals ciclopirox olamine and terbinafine in combating resting spores, which persist in the tissues, and thus in the therapy of recurring dermatomycoses.

Indexed as

Antifungal AgentsCandida albicansCandida parapsilosisCell SurvivalCiclopiroxDermatomycosesEpidermophytonFibroblastsHumansImaging, Three-DimensionalImidazolesInhibitory Concentration 50KeratinocytesLasersMicrobial Sensitivity TestsNephelometry and TurbidimetryAntifungal AgentsCiclopiroxImidazolessertaconazoleTerbinafineThiophenesantifungalciclopirox olaminedermatophytesertaconazole nitratesporicidalterbinafine

Identifiers

PMID35212482
PMCPMC8756736
OpenAlexW4205714791

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.